基于双组分疾病活动度评分的类风湿关节炎炎症缓解标准
本研究利用2C-DAS28制定类风湿关节炎的炎症缓解标准,在早期、确立期和晚期RA队列中确定阈值为2C-DAS28<1.8或下降>1.7,并在独立队列中验证该标准与超声滑膜炎指标显著相关,且3个月应答者6个月疾病活动度更低。
要点
- 2C-DAS28炎症缓解标准为<1.8或较基线下降>1.7。
- 3个月2C-DAS28应答与超声滑膜厚度和能量多普勒评分显著负相关。
- 传统应答标准与超声滑膜炎评分无显著相关性。
核心结论
- 2C-DAS28应答与超声检测的滑膜炎显著相关,并与临床结局改善相关。
- 该标准可能有助于识别持续炎症患者及疾病活动由非炎症特征驱动的患者。
研究设计与样本
- 研究数据来自三个RA治疗阶段队列:早期(甲氨蝶呤,n=1051)、确立期(TNF抑制剂,n=989)和晚期(二线或后续治疗,n=301)。
- 采用受试者工作特征分析和Youden's J确定2C-DAS28阈值,基于Boolean V.2.0缓解和临床疾病活动指数应答。
- 在独立队列(n=161)中评估所提标准与滑膜厚度和能量多普勒的相关性,并与传统应答标准比较。
- 比较3个月2C-DAS28应答者与非应答者的6个月疾病活动度。
主要发现
- 炎症缓解阈值定义为2C-DAS28<1.8或2C-DAS28下降>1.7。
- 验证队列中,3个月2C-DAS28应答与较低滑膜厚度显著相关(r=-0.25,95%CI -0.47至-0.04,p=0.037)。
- 3个月2C-DAS28应答与较低能量多普勒评分显著相关(r=-0.28,95%CI -0.52至-0.04,p=0.042)。
- 传统应答标准与滑膜炎评分无显著相关性。
- 发现队列中,3个月2C-DAS28应答者6个月疾病活动度低于非应答者。
关键数值与推荐
- 炎症应答标准:2C-DAS28<1.8或2C-DAS28下降>1.7。
- 验证队列中2C-DAS28应答与滑膜厚度相关系数r=-0.25(95%CI -0.47至-0.04,p=0.037)。
- 验证队列中2C-DAS28应答与能量多普勒评分相关系数r=-0.28(95%CI -0.52至-0.04,p=0.042)。
临床怎么用
- 可采用2C-DAS28<1.8或下降>1.7作为3个月炎症缓解的评估标准。
- 该标准与超声滑膜炎相关,有助于识别持续炎症或非炎症驱动的疾病活动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop response criteria for rheumatoid arthritis (RA) using the two-component Disease Activity Score in 28 joints (2C-DAS28). METHODS: Data were available for three stages of RA treatment progression, determined by the disease-modifying antirheumatic drug prescribed: early (on methotrexate; n=1051), established (on tumour necrosis factor inhibitors; n=989) and late RA (on second-line or later therapy; n=301). Inflammation response was defined as achieving remission or a clinically meaningful reduction in disease activity after 3 months of treatment. Corresponding 2C-DAS28 thresholds were determined using receiver operating characteristic analysis and Youden's J, based on Boolean V.2.0 remission and clinical disease activity index response. The correlation of the proposed criteria with synovial thickness (ST) and power Doppler (PD) was assessed in an independent cohort (n=161) and compared with conventional response criteria. Finally, 6-month disease activity was compared between 3-month 2C-DAS28 responders and non-responders. RESULTS: Thresholds to define inflammation response were 2C-DAS28<1.8 or a decrease in 2C-DAS28>1.7. In the validation cohort, 3-month 2C-DAS28 response was significantly correlated with lower ST (r=-0.25 (95% CI -0.47 to -0.04), p=0.037) and PD scores (r=-0.28 (95% CI -0.52 to -0.04), p=0.042). By contrast, conventional response criteria showed no significant correlation with synovitis scores. In the discovery cohorts, 3-month 2C-DAS28 responders retained lower disease activity at 6 months than non-responders. CONCLUSION: 2C-DAS28 response correlates significantly with ultrasound-detected synovitis and is associated with improved clinical outcomes. This may support identification of biomarkers of treatment efficacy and clinical stratification, to identify patients with ongoing inflammation and those in whom disease activity is driven by non-inflammatory features.
引用
- Stadler M, Rivellese F, Plant D, et al. Inflammation response criteria for rheumatoid arthritis based on the two-component disease activity score. RMD Open. 2026. PMID: 41802835. doi:10.1136/rmdopen-2025-006631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。